Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

A novel PET tracer shows PDE10A specificity in rat and monkey striatum

May 28, 2013

Liquidia Technologies extends collaboration with PATH

May 22, 2013

FDA grants orphan drug status to ibrutinib, terguride and HIRMAb-IDS

May 21, 2013

The development of probes to determine the therapeutic potential of epigenetic inhibitors

May 21, 2013

A groundbreaking technique to aid accurate network imaging in intact brains

May 21, 2013

One-step generation of transgenic mice with multiple mutations

May 16, 2013

ProQinase and Mercachem obtain E.U. funding

May 15, 2013

Boehringer Ingelheim joins Structural Genomics Consortium on drug discovery projects

May 10, 2013

New point-of-care diagnostic biosensors for the detection of pathogens

May 8, 2013

Ambrx and Bristol-Myers Squibb form new collaboration for antibody-drug conjugates

May 6, 2013

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...